Related Articles
Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway
Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells
TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway
BmK CT enhances the sensitivity of temozolomide-induced apoptosis of malignant glioma U251 cells in vitro through blocking the AKT signaling pathway
Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ